Your browser doesn't support javascript.
loading
Targeting the HuR Oncogenic Role with a New Class of Cytoplasmic Dimerization Inhibitors.
Filippova, Natalia; Yang, Xiuhua; Ananthan, Subramaniam; Calano, Jennifer; Pathak, Vibha; Bratton, Larry; Vekariya, Rakesh H; Zhang, Sixue; Ofori, Edward; Hayward, Emily N; Namkoong, David; Crossman, David K; Crowley, Michael R; King, Peter H; Mobley, James; Nabors, Louis B.
Afiliação
  • Filippova N; Division of Neuro-oncology, Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama.
  • Yang X; Division of Neuro-oncology, Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama.
  • Ananthan S; Drug Discovery Division, Chemistry Department, Southern Research Institute, Birmingham, Alabama.
  • Calano J; Division of Neuro-oncology, Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama.
  • Pathak V; Drug Discovery Division, Chemistry Department, Southern Research Institute, Birmingham, Alabama.
  • Bratton L; Drug Discovery Division, Chemistry Department, Southern Research Institute, Birmingham, Alabama.
  • Vekariya RH; Drug Discovery Division, Chemistry Department, Southern Research Institute, Birmingham, Alabama.
  • Zhang S; Drug Discovery Division, Chemistry Department, Southern Research Institute, Birmingham, Alabama.
  • Ofori E; Drug Discovery Division, Chemistry Department, Southern Research Institute, Birmingham, Alabama.
  • Hayward EN; Division of Neuro-oncology, Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama.
  • Namkoong D; Division of Neuro-oncology, Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama.
  • Crossman DK; Department of Genetics, UAB Genomics Core, University of Alabama at Birmingham, Birmingham, Alabama.
  • Crowley MR; Department of Genetics, UAB Genomics Core, University of Alabama at Birmingham, Birmingham, Alabama.
  • King PH; Department of Neurology, Birmingham Veterans Affairs Medical Center, Birmingham, Alabama.
  • Mobley J; Division of Molecular and Translational Biomedicine, Department of Anesthesiology and Perioperative Medicine, O'Neal Comprehensive Cancer Center MS/Proteomics Shared Facility, University of Alabama at Birmingham, Birmingham, Alabama.
  • Nabors LB; Division of Neuro-oncology, Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama. bnabors@uab.edu.
Cancer Res ; 81(8): 2220-2233, 2021 04 15.
Article em En | MEDLINE | ID: mdl-33602784
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Multimerização Proteica / Carcinogênese / Proteína Semelhante a ELAV 1 Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Multimerização Proteica / Carcinogênese / Proteína Semelhante a ELAV 1 Idioma: En Ano de publicação: 2021 Tipo de documento: Article